(Q44305971)

1 December 2017

title

21-Gene recurrence scores: racial differences in testing, scores, treatment, and outcome (English)

1 reference

1 December 2017

author

Sheryl Gabram-Mendola

4

object named as

Sheryl Gabram-Mendola

1 reference

1 December 2017

Mary Jo Lund

1

1 reference

1 December 2017

Marina Mosunjac

2

1 reference

1 December 2017

Kelly M Davis

3

1 reference

1 December 2017

Monica Rizzo

5

1 reference

1 December 2017

Harvey L Bumpers

6

1 reference

1 December 2017

Sherita Hearn

7

1 reference

1 December 2017

Amelia Zelnak

8

1 reference

1 December 2017

Toncred Styblo

9

1 reference

1 December 2017

Ruth M O'Regan

10

1 reference

1 December 2017

language of work or name

English

0 references

publication date

30 June 2011

1 reference

1 December 2017

1 reference

1 December 2017

volume

118

1 reference

1 December 2017

issue

3

1 reference

1 December 2017

page(s)

788-796

1 reference

Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26180

Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26180

Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26180

Differences in breast cancer stage, treatment, and survival by race and ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26180

Parity and disparity in first course treatment of invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26180

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26180

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26180

Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26180

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26180

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26180

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26180

Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26180

Revision of the American Joint Committee on Cancer staging system for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26180

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26180

A Lower Allred Score for Progesterone Receptor Is Strongly Associated With a Higher Recurrence Score of 21-Gene Assay in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26180

Review of the clinical studies using the 21-gene assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26180

Coprescription of tamoxifen and medications that inhibit CYP2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26180

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26180

Development and clinical utility of a 21-gene recurrence score prognostic assay in patients with early breast cancer treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26180

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.26180

1 reference

1 December 2017

1 reference